ARCHIVES

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

This article is from The Cancer Letter archive.

Vol. 28 No. 23 | June 7, 2002

Download PDF Visit The Full Archive

Related Articles

AACR Reschedules Annual Meeting For July 11-14, in Washington, DC

April 25, 2003

NCI Advisory Group, Other Cancer Meetings

October 26, 1984

Importation Is Remedy of Last Resort in Effort to Obtain Generic Injectables

March 2, 2012

Grand Jury Clears Eppley, Shubik

October 24, 1980

DCT Advisors Approve $22 Mil. Set Aside For Interactive R01s Systemic Therapies

July 10, 1992

Univ. Of Pittsburg Vows To Make Changes To Keep NSABP

April 8, 1994